How genomic testing can address accuracy issues with PSA screening and monitoring

Around the Practice | <b>Around the Practice June 23, 2021: Genomic and Genetic Testing in Prostate Cancer</b>

Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, discusses how the precision of genomic testing data can alleviate the accuracy issues associated with PSA testing for screening and monitoring prostate cancer.

Related Content:

Around the Practice June 23, 2021: Genomic and Genetic Testing in Prostate CancerAround the Practice
Around the Practice July 21, 2021: Bladder Cancer Cases
Genetic, Genomic Testing in Heavily Treated, Metastatic Castrate-Resistant Prostate Cancer
Genetic, Genomic Testing in Newly Diagnosed, High-Grade, High-Risk Prostate Cancer